![]() |
|
|
Vol. 26, Issue 5, 457-464, May 1998
School of Pharmacy, Tokyo University of Pharmacy and
Life Science
Internal acyl migration reactions of drug 1
-O-acyl
glucuronides are of interest because of their possible role in covalent binding to serum proteins and consequent allergic reactions as well as
their influence on drug disposition. An approach using 13C labeling and nuclear magnetic resonance
(NMR) spectroscopy has been used to investigate in situ the
kinetics of acyl migration and hydrolysis of 1
-O-acyl
glucuronides of enantiomeric ketoprofens (KPs) in phosphate buffer
solutions at 37°C. Apparent first-order degradation of the
1
-O-acyl glucuronide labeled in the ester carbonyl
carbon and the sequential appearance of 2-, 3-, and
4-O-acyl isomers as both
- and
-anomeric forms were
observed for each enantiomer. All of the positional isomers and anomers
were characterized using two-dimensional NMR spectroscopy
(heteronuclear multiple bond correlation, correlated spectroscopy,
totally correlated spectroscopy) of the reaction mixtures. The overall
degradation rate constants (hr-1) of
(R)- and (S)-KP glucuronides were 1.07 ± 0.154 and 0.55 ± 0.034, respectively. To evaluate in detail the
stereoselective reactivity, a kinetic model describing the
rearrangement reactions was constructed, and the kinetics were
simulated using a theoretical approach. Only the acyl migration,
1
2
, was found to have significant stereoselectivity. The rate
constants (hr-1) for 1
2
migration of
(R)- and (S)-KP glucuronides were 1.04 ± 0.158 and 0.52 ± 0.029, respectively. The results may suggest that (R)-KP glucuronide could be more susceptible to
covalent binding to proteins via acyl migration than the
corresponding antipode. This stereoselective reactivity may be
responsible for the stereoselective pharmacokinetics of KP. The direct
approach using 13C labeling and NMR
spectroscopy could also provide insight into the reactivities of other
labile drug acyl glucuronides and their isomeric glucuronides.
This article has been cited by other articles:
![]() |
K. Akira, E. Negishi, M. Imachi, and T. Hashimoto Direct Nuclear Magnetic Resonance Spectroscopic Analysis of 13C-Labeled Antipyrine Metabolites in Human Urine Drug Metab. Dispos., June 1, 2001; 29(6): 903 - 907. [Abstract] [Full Text] |
||||
![]() |
R. W. Mortensen, O. Corcoran, C. Cornett, U. G. Sidelmann, J. C. Lindon, J. K. Nicholson, and S. H. Hansen S-Naproxen-{beta}-1-O-acyl Glucuronide Degradation Kinetic Studies by Stopped-Flow High-Performance Liquid Chromatography-1H NMR and High-Performance Liquid Chromatography-UV Drug Metab. Dispos., April 1, 2001; 29(4): 375 - 380. [Abstract] [Full Text] |
||||
![]() |
K. Akira, E. Negishi, C. Sakuma, and T. Hashimoto Direct Detection of Antipyrine Metabolites in Rat Urine by 13C Labeling and NMR Spectroscopy Drug Metab. Dispos., November 1, 1999; 27(11): 1248 - 1253. [Abstract] [Full Text] |
||||